Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No price history available for this symbol yet.
No one on the platform currently holds EPRX.TO.
No tracked institution reports a position in EPRX.TO as of their last filing.
No one on the platform has traded EPRX.TO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $16M | -65.3% | $-1.17 | $-1.56–$-0.68 | — | 10 |
| 2027 | $779361 | -95.1% | $-1.35 | $-2.21–$0.54 | — | 9 |
| 2028 | $23M | +2886.4% | $-1.42 | $-3.00–$0.43 | — | 6 |
| 2029 | $40M | +73.6% | $-1.72 | $-1.72–$-1.72 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-11 | $-0.32 | $-0.22 | +30.6% |
| 2026-05-12 | $-0.26 | $-0.31 | -19.1% |
| 2026-03-19 | $-0.21 | $-0.44 | -111.1% |
| 2025-11-04 | $-0.22 | $-0.24 | -9.4% |
| 2025-08-12 | $-0.25 | $-0.24 | +3.8% |
| 2025-05-06 | $-0.23 | $-0.30 | -30.4% |
| 2025-03-20 | $-0.16 | $-0.28 | -75.0% |
| 2024-11-07 | $-0.19 |
| $-0.23 |
| -21.1% |
| +5.88% |
| $137M |
| — |
| MDNA.TOMedicenna Therapeutics Corp. | $0.40 | -1.23% | $31M | — |
| NGEN.VNervGen Pharma Corp. | $5.15 | +3.00% | $408M | — |
Source: Financial Modeling Prep · peers by sector/industry